Administration, Faculty & Staff

Vietbao Phan earned his PharmD from Thomas Jefferson University in May 2025. His interest in HEOR  began in his first year of pharmacy school through a Pharmacy and Therapeutics (P&T) competition, where he explored formulary decision-making and value-based care. This early exposure laid the foundation for a growing passion for evidence generation and its role in improving healthcare decisions. He later contributed to a scoping review evaluating psychosocial interventions for pregnant women with opioid use disorder, assessing how these interventions impact maternal health outcomes. He also participated in a systematic review examining patient preferences for medication-assisted treatment, emphasizing the role of patient-centered care and shared decision-making in treatment engagement and retention. During his APPE rotation at Merck, he presented a journal club on barriers to patient enrollment in oncology clinical trials, where he analyzed factors influencing patient decision-making, access, and diversity in research participation. His interest in HEOR deepened through coursework in Pharmacoeconomics and Health Outcomes, where he explored the relationship between treatment cost and clinical outcomes across therapeutic areas. Through the JCPH and Novartis Fellowship, Bao aims to advance his skills in generating real-world evidence and applying economic frameworks to inform policy, access, and reimbursement strategies. He is committed to developing actionable insights that drive value-based healthcare and support stakeholders in delivering sustainable, patient-centered care.